Review of treatment strategies after lymphadenectomy: From molecular therapeutics to immediate microsurgical lymphatic reconstruction.

Journal of vascular surgery. Venous and lymphatic disorders 2024 Vol.12(5) p. 101844

Sung C, Wang J, Chang J, Wong AK

관련 도메인

Abstract

[OBJECTIVE] Lymphedema is a common complication of cancer treatment, such as lymphadenectomy and radiation therapy. It is a debilitating condition with pathologic tissue changes that hinder effective curative treatment and jeopardize patients' quality of life. Various attempts to prevent the development of lymphedema have been made, with improvements in the incidence of the pathology. However, it is still prevalent among survivors of cancer. In this paper, we review both molecular therapeutics and immediate surgical lymphatic reconstruction as treatment strategies after lymphadenectomy. Specifically, we discuss pro-lymphangiogenic molecules that have proved efficient in animal models of lymphedema and clinical trials, and review currently available microsurgical techniques of immediate lymphatic reconstruction.

[METHODS] A literature search was conducted in PubMed, Embase, Cochrane Library, and Google Scholar through May 2022. Searches were done separately for molecular therapeutics and microsurgical techniques for immediate lymphatic reconstruction. Search terms used for (1) non-surgical methods include 'lymphangiogenesis,' 'lymphedema,' 'growth factor,' and 'gene therapy.' Search terms used for (2) surgical methods include 'lymphedema,' 'lymph node excision,' 'lymphatic vessels,' 'primary prevention,' and 'microsurgery.'

[RESULTS] Various pro-lymphangiogenic factors with therapeutic potential include VEGF-C, VEGF-D, HGF, bFGF, PDGF, IGF, Retinoic acid, Ang-1, S1P, TLR4, and IL-8. Microsurgical lymphatic reconstruction for prevention of secondary lymphedema includes lymphovenous anastomosis, vascularized lymph node flap transfer, and lymph-interpositional flap transfer, with promising clinical outcomes.

[CONCLUSIONS] With growing knowledge of the lymphangiogenic pathway and lymphedema pathology and advances in microsurgical techniques to restore lymphatic channels, molecular and surgical approaches may represent a promising method for primary prevention of lymphedema.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
시술 flap 피판재건술 dict 2
시술 microsurgery 미세수술 dict 1
해부 lymphatic scispacy 1
해부 tissue scispacy 1
해부 lymphovenous scispacy 1
합병증 lymphedema scispacy 1
약물 Retinoic acid C0040845
tretinoin
scispacy 1
약물 S1P C1423502
MBTPS1 gene
scispacy 1
약물 [OBJECTIVE] Lymphedema scispacy 1
약물 [CONCLUSIONS] scispacy 1
질환 Lymphedema C0024236
Lymphedema
scispacy 1
질환 cancer C0006826
Malignant Neoplasms
scispacy 1
기타 patients scispacy 1
기타 lymphatic scispacy 1
기타 lymph node scispacy 1
기타 lymphatic vessels scispacy 1
기타 VEGF-C scispacy 1
기타 VEGF-D scispacy 1
기타 HGF scispacy 1
기타 bFGF scispacy 1
기타 PDGF scispacy 1
기타 IGF scispacy 1
기타 Ang-1 scispacy 1
기타 S1P scispacy 1
기타 TLR4 scispacy 1
기타 IL-8 scispacy 1

MeSH Terms

Humans; Lymphedema; Microsurgery; Lymph Node Excision; Lymphangiogenesis; Animals; Lymphatic Vessels; Treatment Outcome; Plastic Surgery Procedures; Molecular Targeted Therapy; Neoplasms; Genetic Therapy

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문